ImmuPharma PLC

IMM

Company Profile

  • Business description

    ImmuPharma PLC is a drug discovery and development company. The pipeline of the company includes novel peptide-based therapeutics within two therapy areas: autoimmunity & inflammation and anti-infectives. The company's drug candidate is Lupuzor, which treats lupus, a life-threatening autoimmune disease, and other candidates are P140 CIDP and BioAMB Fungal infections.

  • Contact

    One Bartholomew Close
    LondonEC1A 7BL
    GBR

    T: +44 2072062650

    E: [email protected]

    https://www.immupharma.co.uk

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    4

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,646.3021.400.25%
CAC 407,788.1038.69-0.49%
DAX 4024,038.19188.30-0.78%
Dow JONES (US)42,098.70244.95-0.58%
FTSE 1008,726.0152.04-0.59%
HKSE23,477.79219.480.94%
NASDAQ19,100.9498.22-0.51%
Nikkei 22538,352.14629.741.67%
NZX 50 Index12,281.3180.95-0.65%
S&P 5005,888.5532.99-0.56%
S&P/ASX 2008,419.3022.400.27%
SSE Composite Index3,364.1024.170.72%

Market Movers